Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemipelvectomy: a changing perspective for a rare procedure.

Christopher R Baliski1, Norman S Schachar, J Gregory McKinnon

  • 1Division of General Surgery, Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC. cbaliski@providencehealth.bc.ca

Canadian Journal of Surgery. Journal Canadien De Chirurgie
|May 11, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Not Waiting to Progress; How the COVID-19 Pandemic Nudged Neoadjuvant Therapy for Stage III Locally Advanced Melanoma Patients.

Current oncology (Toronto, Ont.)·2023
Same author

Mitigating Breast-Cancer-Related Lymphedema-A Calgary Program for Immediate Lymphatic Reconstruction (ILR).

Current oncology (Toronto, Ont.)·2023
Same author

Higher Rate of Lymphedema with Inguinal versus Axillary Complete Lymph Node Dissection for Melanoma: A Potential Target for Immediate Lymphatic Reconstruction?

Current oncology (Toronto, Ont.)·2022
Same author

Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma: An International Multi-institutional Collaboration.

Annals of surgical oncology·2022
Same author

Canadian Melanoma Conference Recommendations on High-Risk Melanoma Surveillance: A Report from the 14th Annual Canadian Melanoma Conference; Banff, Alberta; 20-22 February 2020.

Current oncology (Toronto, Ont.)·2021
Same author

Macroscopic and microscopic characteristics of low grade appendiceal mucinous neoplasms (LAMN) on appendectomy specimens and correlations with pseudomyxoma peritonei development risk.

Annals of diagnostic pathology·2020

Hemipelvectomy (HP) offers a potentially curative treatment for pelvic sarcomas, demonstrating better survival rates. However, HP has significant morbidity and was not curative for pelvic carcinomas, providing only short-term local control.

Area of Science:

  • Surgical Oncology
  • Orthopedic Oncology
  • Pelvic Tumor Management

Background:

  • Pelvic sarcomas and carcinomas present complex treatment challenges.
  • Hemipelvectomy (HP) is a radical surgical procedure for extensive pelvic malignancies.
  • Evaluating the outcomes and complications of HP is crucial for patient management.

Purpose of the Study:

  • To compare the prognosis of patients treated with hemipelvectomy (HP) for pelvic sarcomas versus carcinomas.
  • To assess the morbidity and mortality associated with hemipelvectomy (HP).

Main Methods:

  • Retrospective chart review of 13 patients with pelvic malignancies treated between 1983 and 2001.
  • Patients underwent either external or internal hemipelvectomy (HP).
  • Survival, recurrence rates, morbidity, and mortality were analyzed based on histopathology (sarcoma vs. carcinoma).

Related Experiment Videos

Main Results:

  • Hemipelvectomy (HP) was performed for 7 sarcomas and 6 carcinomas.
  • Complications occurred in 10 of 13 patients, with flap necrosis being most common (38%).
  • Disease-specific survival was 86% for sarcoma patients, compared to significantly poorer outcomes for carcinoma patients, who experienced higher recurrence rates.

Conclusions:

  • Hemipelvectomy (HP) is a viable, potentially curative option for pelvic sarcomas, despite considerable morbidity.
  • For pelvic carcinomas, HP provided short-term local control but was not curative.
  • Further research into imaging and quality-of-life studies is needed for optimal patient selection for hemipelvectomy (HP).